BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Mephenytoin

An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.

300+ PubMed studies analyzed · 13 RCTs · Evidence Score: 50.2

Research Domains

Mephenytoin has been studied across 10 research domains including 🫁 Liver & Detox, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🔬 Oncology, 🔬 Inflammation. The primary research focus is 🫁 Liver & Detox with 39% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mephenytoin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Furaldehyde
2 shared targets
Aztreonam
2 shared targets
Pinacidil
2 shared targets
Midodrine
2 shared targets
Carbimazole
2 shared targets
Lactic
2 shared targets
Metaraminol
2 shared targets
Modafinil
2 shared targets
Sulfadoxine
2 shared targets
Felbamate
2 shared targets
Loading evidence profile...

This evidence profile for Mephenytoin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.